SRX246

Global Huntington's Disease Treatment Market Size, Share & Trends Analysis Report 2023-2030 - ResearchAndMarkets.com

Retrieved on: 
Thursday, September 14, 2023
General Health, Science, Health, Research, HD, Huntington's disease, Drug development, Prevalence, Dysphagia, SRX246, HTT, Somnolence, Senior counsel, Disease, ZFP, Quality of life, Brain, Toxicity, II, Compound annual growth rate, Aggression, Investment, Patient, Palliative care, Growth, Irritation, Treatment, Symptomatic treatment, HRQOL, Pharmaceutical industry, Nursing, Vaccine

The "Huntington's Disease Treatment Market Size, Share & Trends Analysis Report By Treatment (Symptomatic Treatment, Disease-Modifying Therapies), By End use, By Region, And Segment Forecasts, 2023-2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Huntington's Disease Treatment Market Size, Share & Trends Analysis Report By Treatment (Symptomatic Treatment, Disease-Modifying Therapies), By End use, By Region, And Segment Forecasts, 2023-2030" report has been added to ResearchAndMarkets.com's offering.
  • The anticipated growth of the global Huntington's disease treatment market is poised to make a significant impact, with projections indicating it will reach a substantial USD 1,871.2 million by 2030, as detailed in this comprehensive report.
  • Huntington's disease, a rare inherited neurodegenerative condition, exerts its impact across multiple generations, severely affecting individuals between the ages of 30 and 50.
  • The symptomatic treatment segment accounted for the largest revenue share in 2022 owing to the product availability and patent protection.

Global Huntington's Disease Treatment Market Size, Share & Trends Analysis Report 2022-2030, Featuring Profiles of H. Lundbeck, Teva Pharmaceutical, Bausch Health Companies and Lupin - ResearchAndMarkets.com

Retrieved on: 
Friday, April 29, 2022
Health, Pharmaceutical, USD, Huntington's disease, Patient, Investment, Topical steroid withdrawal, Apathy, ZFP, Somnolence, SRX246, Prevalence, Growth, Quality of life, Treatment, HD, Scope, Palliative care, Dysphagia, Neurodegeneration, CAGR, Chapter Three, Research, Disease, Brain, Irritation, Symptoms of COVID-19, Aggression, Symptomatic treatment, HTT, HRQOL, Medical device, Pharmaceutical industry, Vaccine

The "Huntington's Disease Treatment Market Size, Share & Trends Analysis Report by Treatment (Symptomatic Treatment, Disease-Modifying Therapies), by Region and Segment Forecasts, 2022-2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Huntington's Disease Treatment Market Size, Share & Trends Analysis Report by Treatment (Symptomatic Treatment, Disease-Modifying Therapies), by Region and Segment Forecasts, 2022-2030" report has been added to ResearchAndMarkets.com's offering.
  • The global Huntington's disease treatment market size is expected to reach USD 1.8 billion by 2030.
  • This growth is due to high R&D investments for new product development, research collaboration, and the high HD burden in western countries.
  • The symptomatic treatment segment accounted for the largest revenue share in 2021 owing to the product availability and patent protection.

US Post-Traumatic Stress Disorder Market Report 2019: Treatments, Pipeline, Epidemiology, Marketed Drugs, Size, Sales, Competitive Landscape 2014-2024

Retrieved on: 
Monday, September 2, 2019
Articles, Psychiatry, Human behavior, Stress, Psychiatric diagnosis, RTT, Post-traumatic, Posttraumatic stress disorder, Psychological trauma, Trauma, Traumatic memories, SRX246

DUBLIN, Sept. 2, 2019 /PRNewswire/ -- The "US Post-Traumatic Stress Disorder Market and Competitive Landscape - 2019" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Sept. 2, 2019 /PRNewswire/ -- The "US Post-Traumatic Stress Disorder Market and Competitive Landscape - 2019" report has been added to ResearchAndMarkets.com's offering.
  • The latest research, US Post-Traumatic Stress Disorder Market and Competitive Landscape Highlights - 2019, provides comprehensive insights into Post-Traumatic Stress Disorder pipeline products, Post-Traumatic Stress Disorder epidemiology, Post-Traumatic Stress Disorder market valuations and forecast, Post-Traumatic Stress Disorder drugs sales and competitive landscape in the US.
  • Post-Traumatic Stress Disorder pipeline: Find out the products in clinical trials for the treatment of Post-Traumatic Stress Disorder by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products
    Post-Traumatic Stress Disorder drugs: Identify key products marketed and prescribed for Post-Traumatic Stress Disorder in the US, including trade name, molecule name, and company
    Post-Traumatic Stress Disorder drugs sales: Find out the sales revenues of Post-Traumatic Stress Disorder drugs in the US
    Post-Traumatic Stress Disorder market valuations: Find out the market size for Post-Traumatic Stress Disorder drugs in 2018 in the US.
  • Find out how the market advanced from 2014 and forecast to 2024
    Post-Traumatic Stress Disorder drugs market share: Find out the market shares for key Post-Traumatic Stress Disorder drugs in the US
    Evaluate commercial market opportunity assessment, positioning, and segmentation for Post-Traumatic Stress Disorder products
    Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.